Janssen vs. Johnson & Johnson

Attribute	Janssen	Johnson & Johnson
Parent Company	Johnson & Johnson	Johnson & Johnson
Founded	1953	1886
Headquarters	Beerse, Belgium	New Brunswick, New Jersey, United States
Products	Pharmaceuticals, vaccines	Pharmaceuticals, medical devices, consumer goods
Revenue	Not publicly disclosed	$82.6 billion (2020)

History

Janssen Pharmaceuticals is a pharmaceutical company that was founded in 1953 by Dr. Paul Janssen in Belgium. It is a subsidiary of Johnson & Johnson, which is a multinational corporation that was founded in 1886 by Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson in the United States. Johnson & Johnson is known for its consumer healthcare products, medical devices, and pharmaceuticals.

Both Janssen and Johnson & Johnson have a long history of innovation and commitment to improving healthcare around the world. Janssen has a strong focus on research and development, while Johnson & Johnson has a diverse portfolio of products and services.

Product Portfolio

Janssen Pharmaceuticals specializes in prescription drugs for a variety of therapeutic areas, including neuroscience, infectious diseases, oncology, and cardiovascular and metabolic diseases. Some of its well-known products include Remicade, Invokana, and Xarelto. On the other hand, Johnson & Johnson offers a wide range of consumer healthcare products, medical devices, and pharmaceuticals through its various subsidiaries, including Janssen, Ethicon, and Neutrogena.

Johnson & Johnson's consumer healthcare products include brands like Band-Aid, Listerine, and Tylenol, while its medical devices range from surgical instruments to contact lenses. The company's pharmaceuticals cover areas such as immunology, oncology, and infectious diseases.

Global Presence

Janssen Pharmaceuticals operates in over 150 countries worldwide and has research and development facilities in Belgium, the United States, and other locations. Johnson & Johnson has a presence in more than 60 countries and sells its products in over 175 countries. The company has manufacturing facilities in various regions, including North America, Europe, and Asia.

Both Janssen and Johnson & Johnson have a strong global presence and are committed to providing healthcare solutions to people around the world. They invest in local communities and work with healthcare professionals to improve access to quality care.

Research and Development

Janssen Pharmaceuticals is known for its innovative research and development efforts, with a focus on discovering new treatments for unmet medical needs. The company invests heavily in scientific research and collaborates with academic institutions and other partners to advance healthcare. Johnson & Johnson also has a strong research and development program, with a focus on developing new therapies and technologies to improve patient outcomes.

Both Janssen and Johnson & Johnson have a track record of bringing breakthrough treatments to market and have received recognition for their contributions to healthcare innovation. They continue to invest in research and development to address the evolving needs of patients and healthcare providers.

Corporate Social Responsibility

Janssen Pharmaceuticals and Johnson & Johnson are committed to corporate social responsibility and sustainability. They have initiatives in place to reduce their environmental impact, promote diversity and inclusion, and support communities in need. Janssen has programs focused on global health, access to healthcare, and environmental stewardship, while Johnson & Johnson has initiatives in areas such as health for humanity, citizenship and sustainability, and disaster relief.

Both companies have received awards and recognition for their corporate social responsibility efforts and are seen as leaders in the healthcare industry. They continue to work towards making a positive impact on society and the environment through their business practices and philanthropic activities.